Dr Agarwal's Eye Hospital board approves merger with Dr Agarwal's Health Care
- Merger between Dr. Agarwal's Eye Hospital and Dr. Agarwal's Health Care becomes effective on November 1, 2026
- Record date for allotment of consideration shares fixed as November 18, 2026
- Exchange ratio: 23 equity shares of transferee for every 2 equity shares of transferor
- Total authorized capital of combined entity increases to ₹110 crore from ₹90 crore
- Board of Dr. Agarwal's Eye Hospital dissolves automatically upon merger effectiveness
*this image is generated using AI for illustrative purposes only.
Dr. Agarwal's Eye Hospital Limited announced that its Board of Directors has approved the effectiveness of the scheme of amalgamation with Dr. Agarwal's Health Care Limited. The merger will become operative from November 1, 2026, following the satisfaction of all regulatory conditions.
The decision follows the receipt of a certified copy of the order from the National Company Law Tribunal (NCLT), Chennai Bench, dated September 30, 2026. The company confirmed that all conditionalities specified under Clause 24 of the Scheme were satisfied upon filing the NCLT order with the Registrar of Companies on October 14, 2026. The appointed date for the amalgamation is April 1, 2026.
Share capital structure changes
Upon the scheme becoming effective, the authorized share capital of the transferee company will increase significantly as the capital from the transferor company merges automatically. The existing equity shares of Dr. Agarwal's Eye Hospital Limited are reclassified to align with the transferee’s face value before consolidation.
| Particulars | Pre-Merger (₹) | Post-Merger (₹) |
|---|---|---|
| Equity Shares (Face Value ₹1) | 54,20,00,000 | 74,20,00,000 |
| Preference Shares (Face Value ₹100) | 35,80,00,000 | 35,80,00,000 |
| Total Authorized Capital | 90,00,00,000 | 110,00,00,000 |
The total authorized share capital rises by ₹20 crore, reflecting the absorption of the transferor company's reclassified equity base.
Record date and exchange ratio
To determine eligible shareholders for the allotment of consideration shares, the Board fixed November 18, 2026, as the record date. Shareholders of Dr. Agarwal's Eye Hospital Limited on this date will receive shares in Dr. Agarwal's Health Care Limited based on the approved swap ratio.
The exchange ratio is set at 23 fully paid-up equity shares of Dr. Agarwal's Health Care Limited (face value ₹1 each) for every 2 fully paid-up equity shares of Dr. Agarwal's Eye Hospital Limited (face value ₹10 each).
Dissolution of transferor board
Pursuant to Clause 23 of the Scheme, the Board noted that upon the Scheme becoming effective on November 1, 2026, Dr. Agarwal's Eye Hospital Limited shall stand dissolved without being wound up. Consequently, the Board of Directors of the transferor company will cease to exist and stand dissolved with effect from the same date. The company's status will be changed to Amalgamated in the records of the Registrar of Companies without any further acts or resolutions.
What the numbers show
The merger results in a 22.2% increase in the total authorized share capital of the combined entity, rising from ₹90 crore to ₹110 crore. This expansion is driven entirely by the addition of ₹20 crore in equity capital, while the preference share component remains unchanged at ₹35.80 crore. The structural shift simplifies the capital framework by consolidating two distinct equity bases into a single class of shares with a uniform face value of ₹1.
Historical Stock Returns for Dr. Agarwal's Health Care
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.54% | -1.98% | -7.27% | +4.66% | -13.52% | +16.59% |
How will the consolidation of Dr. Agarwal's Eye Hospital into Dr. Agarwal's Health Care impact the combined entity's operational synergies and cost efficiencies in the upcoming fiscal year?
What are the projected implications of the 22.2% increase in authorized share capital on the post-merger company's future fundraising capabilities and debt-to-equity ratios?
How do market analysts anticipate the 11.5:1 exchange ratio will influence trading volumes and price discovery for Dr. Agarwal's Health Care Limited shares following the November 18 record date?
19
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
